1 story in the last 7 days
The latest memento medicines news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks memento medicines across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Memento Medicines raised $93 million in Series A funding. The round supports the company's development of precision medicines for neurodegenerative diseases. The financing represents one of the larger early-stage rounds in the biotech sector this year.
Summaries by ByteBrief